September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd ...
September 21, 2009
Feature | Dave Fornell
Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but ...
September 17, 2009
September 17, 2009 - Inflation rates for healthcare supplies are projected to remain unchanged through 2010 ...
September 17, 2009
September 17, 2009 - Lantheus Medical Imaging Inc. today announced the initiation of a Phase 1 clinical study to ...
September 16, 2009
September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is ...
September 15, 2009
Feature | Cristen C. Bolan
In the pre-clinicial trial Expanding the Versatility of Cardiac PET/CT: Feasibility of Delayed Contrast ...
August 19, 2009August 14, 2009 - Lantheus Medical Imaging will continue to allocate its Mo-99 supply to serve as many people as ...
August 14, 2009
August 13, 2009 - The Canadian Prime Minister Stephen Harper expressed disappointment with reports from the ...
August 13, 2009
August 4, 2009 - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has submitted a ...
August 04, 2009
July 29, 2009 – The Society of Nuclear Medicine (SNM) and a coalition of eight other organizations have issued a ...
July 29, 2009
July 28, 2009 – Researchers may be able to predict future severe cardiac events in patients with known, stable ...
July 28, 2009
July 9, 2009 - The U.S. Food and Drug Administration (FDA) and Health Canada have approved the Lantheus Medical ...
July 08, 2009July 8, 2009 - Covidien said today Health Canada approved the company’s abbreviated new drug submission (ANDS) for ...
July 08, 2009June 16, 2009 - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in ...
June 16, 2009